Strenthening hepatitis E prevention and control

Hui ZHUANG
DOI: https://doi.org/10.16505/j.2095-0136.2017.03.002
2017-01-01
Abstract:The hepatitis E virus (HEV) is a major cause of acute hepatitis globally.In developing countries,the virus is transmitted feco-orally,leading to epidemics or sporadic cases.By contrast,in developed countries,HEV transmission occurs from animals to humans as a food-borne zoonosis.There are four major genotypes of HEV (G1-4).Genotypes 1 and 2 (G1 and G2) infect only humans,whilst genotypes 3 and 4 (G3 and G4) have a wider host range including humans and other mammalian animals,especially pigs.Acute hepatitis E cases are mainly self-limited,although the severe disease occurs in pregnancy and in patients with chronic liver disease.Persistent infections are found in immunocompromised patients.Ribavirin is effective for treatment of chronic hepatitis E.The vaccine against HEV has been licensed in China,with high efficacy and a durable anti body response for at least 4-5 years.The key questions for the future research on HEV infections are discussed in this paper.
What problem does this paper attempt to address?